Duet BioTherapeutics Alternatives & Competitors
12 companies similar to Duet BioTherapeutics — A Scopus BioPharma company creating targeted immunotherapies for treatment-resis...
Companies similar to Duet BioTherapeutics
Bicara Therapeutics
Pioneering bifunctional antibodies for targeted tumor modulation
Boston, United States
Trillium Therapeutics Inc.
Clinical stage immuno-oncology company developing innovative therapies for the treatment o...
Cambridge, United States
Surface Oncology Inc.
#lifeunderthesurface #BBJBestPlacesToWork2023,2022,2021 #BostonGlobeTopPlacesToWork2023,2...
Cambridge, United States
Inceptor Bio
Advancing Cell and Gene Therapies to Cure Cancer
Morrisville, United State...
Track all Duet BioTherapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Phio Pharmaceuticals Corp.
Phio’s proprietary RNA interference (RNAi) technology makes immune cells more effective in...
Marlborough, United State...
Elpiscience Biopharmaceuticals
Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-gener...
Shanghai, China
Adicet Bio, Inc
A biotechnology company discovering and developing first-in-class allogeneic gamma delta C...
Redwood City, United Stat...
Xilio Therapeutics, Inc.
Focused on harnessing the immune system to achieve deep and durable clinical responses to...
Waltham, United States
Imugene Limited
Bringing Effective New Treatments And Options To Patients Who Need Them
Australia
Singapore, Singapore
About Duet BioTherapeutics
Duet BioTherapeutics is a biopharmaceutical company that is part of Scopus BioPharma, focused on developing targeted immunotherapies to combat treatment-resistant cancers. The company was founded in 2019 and is headquartered in the United States. Duet BioTherapeutics is pioneering a new category of bispecific oligonucl...
Biopharma, Immunotherapy, Cancer Treatment, Oligonucleotides, Immuno-oncology, BioTherapeutics, Bispecific Treatments, Tumor Microenvironment, Targeted Therapies, Immune Cells, Antigen-presenting Cells, Treatment-resistant Cancers, Pasadena, California, Innovation
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Duet BioTherapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Duet BioTherapeutics on 13 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
